Navigation Links
ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results
Date:5/15/2008

TUCSON, Ariz., May 15 /PRNewswire-FirstCall/ -- ImaRx Therapeutics, Inc. (Nasdaq: IMRX), a biopharmaceutical company developing and commercializing therapies for vascular disorders, today reported financial results for the first quarter ended March 31, 2008 and discussed recent corporate highlights.

Corporate Highlights:

-- Entered into agreement with Abbott Laboratories satisfying remaining

debt obligation under non-recourse promissory note issued in connection

with the Company's urokinase acquisition.

-- Signed letter of intent to sell urokinase inventory and related assets

to Microbix Biosystems for $17 million in cash: $12 million at closing

and $5 million upon achievement of an inventory stability milestone.

-- Identified strategic funding to continue advancement of its core

SonoLysis program upon closing of urokinase divestiture with Microbix

Biosystems.

Bradford A. Zakes, President and CEO of ImaRx stated, "Through the satisfaction of our debt obligation with Abbott under favorable terms and the pending divestiture of our urokinase asset to Microbix, we will have successfully gained access to operating capital that is non-dilutive to our shareholders. Taken together, these events have provided us the strategic alternative to continue the advancement of our core SonoLysis technology within ImaRx."

Financial Results

Revenue for the first quarter ended March 31, 2008 rose to $1.9 million from $1.2 million for the first quarter ended March 31, 2007. Increased sales of urokinase, which ImaRx began commercializing in October 2006, drove the revenue increase for the quarter.

Net loss for the first quarter of 2008 was $2.5 m
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ImaRx Postpones Release of First Quarter 2008 Financial Results
2. ImaRx Schedules Release of First Quarter 2008 Financial Results
3. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
4. ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase
5. ImaRx Therapeutics Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQs Minimum Bid Price Requirement
6. ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
7. ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
8. ImaRx to Report Corporate Updates and 4Q07 Financial Results
9. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
10. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Nile Therapeutics Reports 2008 First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... | RBJ today announces the firm brokered a long-term lease ... leading biopharmaceutical company, at Two Ledgemont Center in ... , president, and Brian Cohen , senior vice president, ... at 95 Hayden Ave. Photo - http://photos.prnewswire.com/prnh/20150122/170765 ...
(Date:1/22/2015)... Johnston, RI (PRWEB) January 22, 2015 ... State , The growing team of brand-neutral, independent consultants, ... CIO Philip Rogers explained that over the years, his ... including , Moroso, Town of Plainfield, as well as ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Controlled Substance ... Alliance, which helps companies check the legal requirements around ... expand to China. , As their international operations ... globally adopting software solutions built as a result of ...
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2
... S and CHT , Ceramic ... Henry Lai, PhD, and Samuel G Franklin, PhD, Bio-Rad Laboratories, Inc., , ... , Introduction , ... , using the conventional process composed of a protein ...
... , , ... isolates RNA or cDNA from in vitro ... antisense RNA amplification reactions. As gene expression profiling , ... , effective, automated purification reagent is required. ...
... RNAPrep is a SPRI based magnetic bead purification ... from, Eukaryotic cultured cells. RNAPrep is a simple ... RNA for use in applications such as microarray , ... format is scalable and consistently delivers high yield recovery and purity , ...
Cached Biology Technology:Purification of Murine IgG1 Using UNOsphere S and CHT , Ceramic Hydroxyapatite Chromatography, Rev A 2Purification of Murine IgG1 Using UNOsphere S and CHT , Ceramic Hydroxyapatite Chromatography, Rev A 3Purification of Murine IgG1 Using UNOsphere S and CHT , Ceramic Hydroxyapatite Chromatography, Rev A 4RNA & cDNA Purification Using RNAClean 2RNA & cDNA Purification Using RNAClean 3RNA & cDNA Purification Using RNAClean 4RNA & cDNA Purification Using RNAClean 5RNAPrep - Total RNA Isolation Purification 2RNAPrep - Total RNA Isolation Purification 3
(Date:12/17/2014)... RALEIGH, N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ...
(Date:12/11/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Biometrics Market in India ... One major trend emerging in this market is the ... more than one characteristic of an individual for verification ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced plans ... Medicine. Funding for this $50 million capital project is part ... next summer. The medical education building will ... Company complex, adjacent to 525@vine in Wake Forest Innovation Quarter. ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Climate-KIC, Europe,s largest public-private innovation partnership working to address ... to FuME (Fugitive Methane Emissions), a new project that ... methane emissions are of great importance to climate change ... its high global warming impact . Capturing fugitive methane ...
... cellular heaven and hell, a crane fly sperm cell undergoing ... recognized with the top three awards in the American Society ... for 2013. The awards were announced and the ... , Dec. 14, in New Orleans. The Celldance Awards Ceremony ...
... Reindeer, from Northern Europe or Asia, are often thought of ... Caribou, similar in appearance but living in the wilderness of ... adventurous life. However, new research published in the journal ... about these two animals than previously thought and change in ...
Cached Biology News:Tailored methane measurement services are to be developed for shale gas extraction, municipal waste 2Tailored methane measurement services are to be developed for shale gas extraction, municipal waste 3Celldance 2013 video awards, the 'Cell Oscars,' roll out tiny red carpet 2Celldance 2013 video awards, the 'Cell Oscars,' roll out tiny red carpet 3Climate change will endanger caribou habitat, study says 2
ANTI-RAT ADHESION MARKERS, CDs, CYTOKINES, ETC Rat ICAM PE - Mouse IgG1...
Reacts with methylated DNA from plants and vertebrates...
...
Phospho-4E-BP1 (Thr37/46) (236B4) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
Biology Products: